The DOI matches its Crossref record; 158 of the 158 references it cites were found in a registry or an index.
Interferences With Thyroid Function Immunoassays: Clinical Implications and Detection Algorithm
Open accessAbstract
Automated immunoassays used to evaluate thyroid function are vulnerable to different types of interference that can affect clinical decisions. This review provides a detailed overview of the six main types of interference known to affect measurements of thyroid stimulating hormone (TSH), free thyroxine (T4) and free triiodothyronine (T3): macro-TSH, biotin, antistreptavidin antibodies, anti-ruthenium antibodies, thyroid hormone autoantibodies, and heterophilic antibodies. Because the prevalence of some of these conditions has been reported to approach 1% and the frequency of testing for thyroid dysfunction is important, the scale of the problem might be tremendous. Potential interferences in thyroid function testing should always be suspected whenever clinical or biochemical discrepancies arise. Their identification usually relies on additional laboratory tests, including assay method comparison, dilution procedures, blocking reagents studies, and polyethylene glycol precipitation. Based on the pattern of thyroid function test alterations, to screen for the six aforementioned types of interference, we propose a detection algorithm, which should facilitate their identification in clinical practice. The review also evaluates the clinical impact of thyroid interference on immunoassays. On review of reported data from more than 150 patients, we found that ≥50% of documented thyroid interferences led to misdiagnosis and/or inappropriate management, including prescription of an unnecessary treatment (with adverse effects in some situations), inappropriate suppression or modification of an ongoing treatment, or use of unnecessary complementary tests such as an I123 thyroid scan. Strong interaction between the clinician and the laboratory is necessary to avoid such pitfalls.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“interference from heterophilic antibodies can result in both low and high measures, with elevated values being more common.”
From Refractory hypothyroidism: unraveling the complexities of diagnosis and management (2023) · cites this paper as [81]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Rarely, more extreme analytical errors are present137 (Table 5).”
In the citing paper
“A number of medications can affect the thyroid function tests not only by interfering with the synthesis, transport, and metabolism of TSH and thyroid hormones but also by interfering with thyroid function immunoassays (30, 37–40) ( Table 1 ).”
From Levothyroxine therapy in elderly patients with hypothyroidism (2021) · cites this paper as [38]
In the citing paper
“Furthermore, assay variability, potential interference with rheumatoid factors or heterophilic antibodies, occasional cases of macro-TSH, the observed age related shift towards higher TSH concentrations in older iodine sufficient patients, and obesity may affect this population based sample to an extent.45 46 47 48”
From Thyroid replacement therapy, thyroid stimulating hormone concentrations, and long term health outcomes in patients with hypothyroidism: longitudinal study (2019) · cites this paper as [45]
In the citing paper
“It is worth highlighting that whilst immunoassay platforms are currently the method of choice for the measurement of thyroid function tests [116], there are limitations; as well as macro-TSH, interference from biotin, thyroid hormone autoantibodies, heterophilic antibodies, antistreptavidin antibodies, anti-ruthenium antibodies, and heterophilic antibodies can occur [116].”
From Age-related variation in thyroid function – a narrative review highlighting important implications for research and clinical practice (2023) · cites this paper as [116]
In the citing paper
“It is worth highlighting that whilst immunoassay platforms are currently the method of choice for the measurement of thyroid function tests [116], there are limitations; as well as macro-TSH, interference from biotin, thyroid hormone autoantibodies, heterophilic antibodies, antistreptavidin antibodies, anti-ruthenium antibodies, and heterophilic antibodies can occur [116].”
From Age-related variation in thyroid function – a narrative review highlighting important implications for research and clinical practice (2023) · cites this paper as [116]
In the citing paper
“Low free T4 combined with inappropriately low or normal TSH is also frequent in several other situations where treatment is not required, e.g.due to heterophilic antibodies or other interfering factors in the serum of the patient/person under study (Favresse et al., 2018).”
From The hypothalamus-pituitary-thyroid (HPT)-axis and its role in physiology and pathophysiology of other hypothalamus-pituitary functions (2021) · cites this paper as Favresse et al., 2018
In the citing paper
“Biotin, antistreptavidin antibodies, antiruthenium antibodies, and thyroid hormone autoantibodies provide other sources of interference with the TSH test that may lead to an aberrant result [36].”
From Challenges in Interpreting Thyroid Stimulating Hormone Results in the Diagnosis of Thyroid Dysfunction (2019) · cites this paper as [36]
In the citing paper
“Immunoassay platforms can be susceptible to interferences, potentially leading to incorrect clinical decisions.”
From Refractory hypothyroidism: unraveling the complexities of diagnosis and management (2023) · cites this paper as [81]
In the citing paper
“Suspecting macro-TSH interference is advised with isolated TSH elevation (typically higher than 10 mUI/L) and thyroid hormones within the upper normal range, without clinical evidence of thyroid dysfunction.”
From Refractory hypothyroidism: unraveling the complexities of diagnosis and management (2023) · cites this paper as [81]
In the citing paper
“Anti-T4 and anti-T3 autoantibodies, found in 40% of autoimmune thyroid disease cases, can lead to false hormone elevations”
From Refractory hypothyroidism: unraveling the complexities of diagnosis and management (2023) · cites this paper as [81]
In the citing paper
“Biotin (in doses higher than 1.5 mg/d) can cause falsely low TSH levels and elevated fT4 and fT3, with its impact depending on the platform used, and being avoided with a washout period.”
From Refractory hypothyroidism: unraveling the complexities of diagnosis and management (2023) · cites this paper as [81]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fundamentals of Clinical Chemistry.
(1977) · Annals of Internal Medicine · doi:10.7326/0003-4819-87-1-142_1 · Cited by 2,624
The Clinical Significance of Subclinical Thyroid Dysfunction
Biondi, B., & Cooper, D. S. (2008) · Endocrine Reviews · doi:10.1210/er.2006-0043 · Cited by 1,418
Tietz Fundamentals of Clinical Chemistry
Burtis, E. B. C. A., & Ashwood, E. R. (1996) · Cited by 919
The biotin-(strept)avidin system: principles and applications in biotechnology
Diamandis, E. P., & Christopoulos, T. K. (1991) · Clinical Chemistry · doi:10.1093/clinchem/37.5.625 · Cited by 748
Human Anti-Animal Antibody Interferences in Immunological Assays
Kricka, L. J. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.7.942 · Cited by 581
Tate, J. R., & Ward, G. (2004) · PubMed · Cited by 426
Park, J. Y., & Kricka, L. J. (2013) · Elsevier eBooks · doi:10.1016/b978-0-08-097037-0.00027-0 · Cited by 372
The thyroxine-binding proteins
Schussler, G. C. (2000) · Thyroid · doi:10.1089/thy.2000.10.141 · Cited by 329
Evidence‐based (S3) guideline for the treatment of androgenetic alopecia in women and in men
Blumeyer, A., Tosti, A., Messenger, A. G., Reygagne, P., del Mármol, V., Spuls, P. I., Trakatelli, M. G., Finner, A. M., Kiesewetter, F., Trüeb, R. M., et al. (2011) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/j.1610-0379.2011.07802.x · Cited by 304
Central Hypothyroidism: Pathogenic, Diagnostic, and Therapeutic Challenges
Persani, L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1616 · Cited by 295
Cited by
Sorted by citations
Chaker, L., Razvi, S., Bensenor, I. M., Azizi, F., Pearce, E. N., & Peeters, R. P. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00357-7 · Cited by 330
Lee, S. Y., & Pearce, E. N. (2023) · JAMA · doi:10.1001/jama.2023.19052 · Cited by 364
Nonspecific Binding—Fundamental Concepts and Consequences for Biosensing Applications
Frutiger, A., Tanno, A., Hwu, S., Tiefenauer, R. F., Vörös, J., & Nakatsuka, N. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00044 · Cited by 287
Hyperthyroidism: aetiology, pathogenesis, diagnosis, management, complications, and prognosis
Wiersinga, W. M., Poppe, K. G., & Effraimidis, G. (2023) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(23)00005-0 · Cited by 254
D-dimer: Preanalytical, analytical, postanalytical variables, and clinical applications
Favresse, J., Lippi, G., Roy, P., Châtelain, B., Jacqmin, H., Cate, H. T., & Mullier, F. (2018) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2018.1529734 · Cited by 222
Feldt-Rasmussen, U., Effraimidis, G., & Klose, M. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111173 · Cited by 170
Burch, H. B. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1901214 · Cited by 164
Thayakaran, R., Adderley, N. J., Sainsbury, C., Torlinska, B., Boelaert, K., Šumilo, D., Price, M., Thomas, G. N., Toulis, K. A., & Nirantharakumar, K. (2019) · BMJ · doi:10.1136/bmj.l4892 · Cited by 138
Hormone Immunoassay Interference: A 2021 Update
Ghazal, K., Brabant, S., Prié, D., & Piketty, M. (2021) · Annals of Laboratory Medicine · doi:10.3343/alm.2022.42.1.3 · Cited by 130
Interferences in immunoassays: review and practical algorithm
Wauthier, L., Plebani, M., & Favresse, J. (2022) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2021-1288 · Cited by 125
A 2019 update on TSH-secreting pituitary adenomas
Beck-Peccoz, P., Giavoli, C., & Lania, A. (2019) · Journal of Endocrinological Investigation · doi:10.1007/s40618-019-01066-x · Cited by 111
Mrazek, C., Keppel, M. H., Cadamuro, J., Haschke‐Becher, E., Oberkofler, H., Felder, T. K., & Lippi, G. (2020) · Biochemia Medica · doi:10.11613/bm.2020.020502 · Cited by 135
Van Uytfanghe, K., Ehrenkranz, J., Halsall, D., Hoff, K., Loh, T. P., Spencer, C. A., Köhrle, J., & ATA Thyroid Function Tests Writing Group (2023) · Thyroid® · doi:10.1089/thy.2023.0169 · Cited by 100
“136 Rarely, more extreme analytical errors are present 137 (Table 5).”
BackgroundRazvi, S., Bhana, S., & Mrabeti, S. (2019) · Journal of Thyroid Research · doi:10.1155/2019/4106816 · Cited by 90
“Biotin, antistreptavidin antibodies, antiruthenium antibodies, and thyroid hormone autoantibodies provide other sources of interference with the TSH test that may lead to an aberrant result [36].”
BackgroundBioreceptors as the key components for electrochemical biosensing in medicine
Wang, X., Zhou, J., & Wang, H. (2024) · Cell Reports Physical Science · doi:10.1016/j.xcrp.2024.101801 · Cited by 102
Taylor, P. N., Lansdown, A., Witczak, J., Khan, R., Rees, A., Dayan, C. M., & Okosieme, O. (2023) · Thyroid Research · doi:10.1186/s13044-023-00149-5 · Cited by 72
“implications It is worth highlighting that whilst immunoassay platforms are currently the method of choice for the measurement of thyroid function tests [116], there are limitations; as well as macro-TSH, interference from biotin, thyroid hormone autoantibodies, heterophilic antibodies, antistreptavidin antibodies, an…”
BackgroundBest practices in mitigating the risk of biotin interference with laboratory testing
Bowen, R. A. R., Benavides, R., Colón-Franco, J. M., Katzman, B. M., Muthukumar, A., Sadrzadeh, H. S. M., Straseski, J. A., Klause, U., & Tran, N. K. (2019) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2019.08.012 · Cited by 66
Thyroid hormone system disrupting chemicals
Köhrle, J., & Frädrich, C. (2021) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2021.101562 · Cited by 72
Levothyroxine therapy in elderly patients with hypothyroidism
Effraimidis, G., Watt, T., & Feldt-Rasmussen, U. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.641560 · Cited by 60
Hammarsten, O., Warner, J., Lam, L., Kavsak, P. A., Lindahl, B., Aakre, K. M., Collinson, P. O., Jaffe, A. S., Saenger, A. K., Body, R. M., et al. (2023) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2023-0028 · Cited by 59
Persani, L., Rodien, P., Moran, C., Visser, W., Groeneweg, S., Peeters, R. P., Refetoff, S., Gurnell, M., Beck-Peccoz, P., & Chatterjee, K. (2024) · European Thyroid Journal · doi:10.1530/etj-24-0125 · Cited by 39
MANAGEMENT OF ENDOCRINE DISEASE Subclinical hypothyroidism in children
Salerno, M., Improda, N., & Capalbo, D. (2020) · European Journal of Endocrinology · doi:10.1530/eje-20-0051 · Cited by 52
D-dimer testing: A narrative review
Wauthier, L., Favresse, J., Hardy, M. J., Douxfils, J., Gal, G. L., Roy, P., van Es, N., Ay, C., Cate, H. T., Lecompte, T., et al. (2023) · Advances in clinical chemistry · doi:10.1016/bs.acc.2023.02.006 · Cited by 49
Haddad, R. A., Giacherio, D. A., & Barkan, A. L. (2019) · Clinical Diabetes and Endocrinology · doi:10.1186/s40842-019-0086-7 · Cited by 47
Biotin interference in assays for thyroid hormones, thyrotropin and thyroglobulin
Ylli, D., Soldin, S. J., Stolze, B., Wei, B., Nigussie, G., Nguyen, H., Mendu, D. R., Mete, M., Wu, D., Gomes-Lima, C. J., et al. (2021) · Thyroid · doi:10.1089/thy.2020.0866 · Cited by 44
Laboratory Thyroid Tests: A Historical Perspective
Spencer, C. A. (2023) · Thyroid · doi:10.1089/thy.2022.0397 · Cited by 34
Kidney disease and thyroid dysfunction: the chicken or egg problem
Echterdiek, F., Ranke, M. B., Schwenger, V., Heemann, U. W., & Latus, J. (2022) · Pediatric Nephrology · doi:10.1007/s00467-022-05640-z · Cited by 31
Approach to the Patient With Raised Thyroid Hormones and Nonsuppressed TSH
Moran, C., Schoenmakers, N. A., Halsall, D. J., Oddy, S., Lyons, G., van den Berg, S. A. A., Gurnell, M., & Chatterjee, K. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad681 · Cited by 29
Mutational Landscape of Resistance to Thyroid Hormone Beta (RTHβ)
Concolino, P., Costella, A., & Paragliola, R. M. (2019) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-019-00399-w · Cited by 33
Macro vitamin B12: an underestimated threat
Soleimani, R., Favresse, J., Roy, T., Gruson, D., & Fillée, C. (2019) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2019-0999 · Cited by 29
Independent and combined effects of biotin and hemolysis on high-sensitivity cardiac troponin assays
Harley, K., Bissonnette, S., Inzitari, R., Schulz, K. M., Apple, F. S., Kavsak, P. A., & Gunsolus, I. L. (2021) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2021-0124 · Cited by 28
D’Aurizio, F., Kratzsch, J., Gruson, D., Ovčariček, P. P., & Giovanella, L. (2022) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2022.2121960 · Cited by 31
Zaninotto, M., & Plebani, M. (2019) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2019-0898 · Cited by 25
Thyroid Hormone Abuse in Elite Sports: The Regulatory Challenge
Gild, M. L., Stuart, M. C., Clifton-Bligh, R. J., Kinahan, A., & Handelsman, D. J. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac223 · Cited by 28
Mzougui, S., Favresse, J., Soleimani, R., Fillée, C., & Gruson, D. (2020) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2020-0214 · Cited by 24
Risks of suboptimal and excessive thyroid hormone replacement across ages
Feldt-Rasmussen, U., Effraimidis, G., Bliddal, S., & Klose, M. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02229-7 · Cited by 23
Familial Dysalbuminemic Hyperthyroxinemia: An Underdiagnosed Entity
Dieu, X., Bouzamondo, N., Briet, C., Illouz, F., Moal, V., de Casson, F. B., Bouhours‐Nouet, N., Reynier, P., Coutant, R., Rodien, P., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9072105 · Cited by 23
Subclinical hypothyroidism in children: updates for pediatricians
Metwalley, K. A., & Farghaly, H. S. (2021) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2040242.121 · Cited by 23
Methods for analyzing positive cardiac troponin assay interference
Hammarsten, O., Becker, C., & Engberg, A. E. (2023) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2023.03.004 · Cited by 23
Khoo, S. S. K., Lyons, G., McGowan, A., Gurnell, M., Oddy, S., Visser, W. E., van den Berg, S. A. A., Halsall, D. J., Taylor, K., Chatterjee, K., et al. (2020) · European Journal of Endocrinology · doi:10.1530/eje-19-1021 · Cited by 22
Macro-TSH: A Diagnostic Challenge
Larsen, C. B., Petersen, E. R. B., Overgaard, M., & Bonnema, S. J. (2020) · European Thyroid Journal · doi:10.1159/000509184 · Cited by 21
Goichot, B., Raverot, V., Klein, M., Racaru, L. V., Payrat, J. A.-D., Lairez, O., Leroy, R., Cailleux, A., Wolff, P., Groussin, L., et al. (2020) · Annales d Endocrinologie · doi:10.1016/j.ando.2020.04.010 · Cited by 18
Artificial intelligence and thyroid disease management
Gruson, D., Stankovic, S. D., Macq, B. M. M., Bernardini, S., Gouget, B., Homšak, E., & Dabla, P. K. (2022) · Biochemia Medica · doi:10.11613/bm.2022.020601 · Cited by 18
Padoan, A., Clerico, A., Zaninotto, M., Trenti, T., Tozzoli, R., Aloe, R., Alfano, A., Rizzardi, S., Dittadi, R., Migliardi, M., et al. (2020) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2019-1167 · Cited by 19
Laboratory interference in the thyroid function test
Paczkowska, K., Otlewska, A., Loska, O., Kolačkov, K., Bolanowski, M., & Daroszewski, J. (2020) · Endokrynologia Polska · doi:10.5603/ep.a2020.0079 · Cited by 17
Westbye, A. B., Aas, F. E., Kelp, O., Dahll, L. K., & Thorsby, P. M. (2023) · Analytical Science Advances · doi:10.1002/ansa.202200067 · Cited by 16
Managing symptoms in hypothyroid patients on adequate levothyroxine: a narrative review
Razvi, S., Mrabeti, S., & Luster, M. (2020) · Endocrine Connections · doi:10.1530/ec-20-0205 · Cited by 15
“8%) may interfere directly with a TSH test, providing aberrant results [72].”
BackgroundOhba, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126611 · Cited by 15
Diagnostic, Theranostic and Prognostic Value of Thyroglobulin in Thyroid Cancer
Giovanella, L., D’Aurizio, F., Ovčariček, P. P., & Görges, R. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13092463 · Cited by 15
Kanegusuku, A. G., Araque, K., Nguyen, H., Wei, B., Hosseini, S., & Soldin, S. J. (2021) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018821989240 · Cited by 15
Fitzgerald, S. P., & Falhammar, H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.920854 · Cited by 17
Dahll, L. K., Haave, E. M., Dahl, S. R., Aas, F. E., & Thorsby, P. M. (2021) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365513.2020.1858493 · Cited by 15
Heterophilic antibody interference with TSH measurement on different immunoassay platforms
Cheng, X., Guo, X., Chai, X., Hu, Y., Lian, X., & Zhang, G. (2021) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.11.018 · Cited by 14
Assessment of thyroid function tests and harmonization: opinion on thyroid hormone harmonization
Araque, K. A., Klubo-Gwiezdzinska, J., Nieman, L. K., Welsh, K., & Soldin, S. J. (2019) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018819897049 · Cited by 14
A case of macro-TSH consisting of IgA-bound TSH
Fukushita, M., Watanabe, N., Noh, J. Y., Yoshihara, A., Matsumoto, M., Suzuki, N., Yoshimura, R., Sugino, K., & Ito, K. (2021) · Endocrine Journal · doi:10.1507/endocrj.ej21-0021 · Cited by 14
Thyroglobulin Assay Interferences: Clinical Usefulness of Mass-Spectrometry Methods
Barbesino, G., Algeciras‐Schimnich, A., & Bornhorst, J. A. (2022) · Journal of the Endocrine Society · doi:10.1210/jendso/bvac169 · Cited by 14
Impact of subclinical hypothyroidism on health‐related quality of life: a narrative review
Danicic, J. M., Inder, W. J., & Kotowicz, M. A. (2021) · Internal Medicine Journal · doi:10.1111/imj.15431 · Cited by 15
Campi, I., Dell’Acqua, M., Stellaria Grassi, E., Cristina Vigone, M., & Persani, L. (2023) · European Thyroid Journal · doi:10.1530/etj-23-0012 · Cited by 13
Apparent resistance to thyroid hormones: From biological interference to genetics
Dieu, X., Sueur, G., Moal, V., Boux de Casson, F., Bouzamondo, N., Bouhours, N., Briet, C., Illouz, F., Reynier, P., Coutant, R., et al. (2019) · Annales d'Endocrinologie · doi:10.1016/j.ando.2019.06.005 · Cited by 12
Refractory hypothyroidism: unraveling the complexities of diagnosis and management
Quiroz-Aldave, J. E., Concepción-Zavaleta, M. J., Durand-Vásquez, M. D. C., Concepción-Urteaga, L. A., Gamarra-Osorio, E. R., Suárez-Rojas, J., Rafael-Robles, L. D. P., Paz-Ibarra, J., & Román-González, A. (2023) · Endocrine Practice · doi:10.1016/j.eprac.2023.09.003 · Cited by 14
Management of thyroid dysfunction and thyroid nodules in the ageing patient
Martínez‐Montoro, J. I., Doulatram‐Gamgaram, V. K., Olveira, G., Valdés, S., & Fernández‐García, J. C. (2023) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2023.06.005 · Cited by 13
Westbye, A. B., Aas, F. E., Dahl, S. R., Zykova, S. N., Kelp, O., Dahll, L. K., & Thorsby, P. M. (2023) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2023.110676 · Cited by 13
Erroneous thyroid and steroid hormones profile due to anti-streptavidin antibodies
Bayart, J., Favresse, J., Melnik, E., Lardinois, B., Fillée, C., Maiter, D. M., & Gruson, P. D. (2019) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2018-1355 · Cited by 13
The role of laboratory medicine in the diagnosis of the hyperthyroidism
D’Aurizio, F. (2021) · The Quarterly Journal of Nuclear Medicine and Molecular Imaging · doi:10.23736/s1824-4785.21.03344-6 · Cited by 13
Matejek, N., Tittel, S. R., Haberland, H., Rohrer, T. R., Busemann, E.-M., Jorch, N., Schwab, K., Woelfle, J., Holl, R. W., & Bettendorf, M. (2021) · European Journal of Pediatrics · doi:10.1007/s00431-021-04031-0 · Cited by 13
Biotin interferences: Have we neglected the impact on serological markers?
Bayart, J., Favresse, J., Stoefs, A., Closset, M., Roy, T., Fillée, C., Rodriguez‐Villalobos, H., Kabamba‐Mukadi, B., & Gruson, D. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.01.012 · Cited by 12
Chen, Z., Huang, A.-J., Luo, L. G., Xu, Z.-L., & Wang, H. (2023) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2023.115872 · Cited by 12
Keen, F., Chalishazar, A., Mitchem, K., Dodd, A., & Kalhan, A. (2022) · European Thyroid Journal · doi:10.1530/etj-21-0119 · Cited by 12
Approach to the Patient With a Suppressed TSH
Praw, S. S., & Brent, G. A. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac635 · Cited by 13
Mairesse, A., Wauthier, L., Courcelles, L., Luyten, U., Burlacu, M., Maisin, D., Favresse, J., van Dievoet, M., & Gruson, D. (2021) · Clinical Endocrinology · doi:10.1111/cen.14356 · Cited by 11
Self-citationRibera, A., Zhang, L., Dabbs‐Brown, A., Sugahara, O., Poynter, K., Uytfanghe, K. V., Shimizu, E., van Herwaarden, A. E., Botelho, J. C., Danilenko, U., et al. (2023) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2023.03.010 · Cited by 11
Delgado, J. A., García, M. I. P., Bauçà, J. M., Mullor, R. V., & Barceló, A. (2020) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2019-1010 · Cited by 10
Țaranu, I., Lazea, C., Creț, V., Răcătăianu, N., Iancu, M., & Bolboaca, S. D. (2021) · Diagnostics · doi:10.3390/diagnostics11030485 · Cited by 10
Koch, C. A., & Petersenn, S. (2018) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-018-9472-1 · Cited by 10
Stieglitz, H. M., & Korpi-Steiner, N. L. (2019) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2019.09.006 · Cited by 9
Immunoassay Interference on Thyroid Function Tests During Treatment with Nivolumab
Paragliola, R. M., Corsello, A., Papi, G., Melfa, E., Urbani, A., Pontecorvi, A., Corsello, S. M., & Carrozza, C. (2020) · Thyroid · doi:10.1089/thy.2019.0799 · Cited by 10
Familial Dysalbuminemic Hyperthyroxinemia as a Cause for Discordant Thyroid Function Tests
Ting, M. J. M., Zhang, R., Lim, E. M., Ward, B. K., Wilson, S. G., & Walsh, J. P. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvab012 · Cited by 9
Jin, Y., Zhai, T., Wang, Y., Li, J., Wang, T., & Huang, J. (2024) · Journal of Separation Science · doi:10.1002/jssc.202400466 · Cited by 9
Thyrotropin reference interval in older adults
Zhai, X., Li, Y. J., Teng, X., Teng, W., Shi, X., & Shan, Z. (2024) · Endocrine Connections · doi:10.1530/ec-24-0435 · Cited by 9
Circulating Biomarkers of Thyroid Cancer: An Appraisal
Codrich, M., Biasotto, A., & D’Aurizio, F. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14051582 · Cited by 10
Two-site evaluation of the Roche Elecsys Vitamin D total III assay
Favresse, J., Schiettecatte, J., Wolff, F., COTTON, F. J., Elsen, M., Eucher, C., Rosseels, C., & Anckaert, E. (2022) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2022-0177 · Cited by 9
Jiang, F., Liu, J., Li, Y., Lu, Z., Liu, Q., Xing, Y., Zhu, J., Huang, M., & Zhong, G. (2024) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2024.02.008 · Cited by 9
Zhu, C., Liu, T., Yu, H., Chang, L., Zhang, X., Yao, J., Zhang, G., Chen, Q., He, Q., & Liu, M. R. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1301260 · Cited by 9
Ohba, K., Maekawa, M., Iwahara, K., Suzuki, Y., Matsushita, A., Sasaki, S., Oki, Y., & Nakamura, H. (2019) · Endocrine Journal · doi:10.1507/endocrj.ej19-0320 · Cited by 9
Favresse, J., Bayart, J., Stoefs, A., Gheldof, D. D., Douxfils, J., Dogné, J., & Gruson, D. (2020) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2019-1121 · Cited by 9
Mirjanić-Azarić, B., Jerin, A., & Savic, Z. R. (2019) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365513.2019.1703215 · Cited by 9
Brito, D. M., Leogrande, P., Donati, F., de la Torre, X., & Botrè, F. (2022) · Drug Testing and Analysis · doi:10.1002/dta.3269 · Cited by 9
Spurious Serum Hormone Immunoassay Results: Causes, Recognition, Management
Braunstein, G. D. (2022) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2022.18.2.141 · Cited by 9
The Complex Web of Interferences with Thyroid Function Tests
Al-Bahadili, H., Powers Carson, J., Markov, A., & Jasim, S. (2025) · Endocrine Practice · doi:10.1016/j.eprac.2024.10.007 · Cited by 8
Timmons, J. G., & Mukhopadhyay, B. (2020) · HORMONES · doi:10.1007/s42000-020-00180-3 · Cited by 8
Ramzy, A., Saber, N., Bruin, J. E., Thompson, D. M., Kim, P. T. W., Warnock, G. L., & Kieffer, T. J. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad499 · Cited by 7
Clinically Symptomatic Resistance to Thyroid Hormone β Syndrome Because of THRB Gene Mosaicism
Donnars, A., Leplat, A., Grosheny, C., Briet, C., Illouz, F., Bouzamondo, N., Moal, V., de Casson, F. B., Bouhours‐Nouet, N., Coutant, R., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac347 · Cited by 8
Tokumaru, M., Ohba, K., Kashiwabara, Y., Takase, H., Hayashi, C., Iwaki, T., Suzuki, Y., Matsushita, A., Sasaki, S., Suda, T., et al. (2023) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/00045632231159280 · Cited by 8
Unexplained Hyperthyrotropinemia: A Biochemical and Clinical Challenge
Croce, L., Chytiris, S., Coperchini, F., Ferraro, G., Minelli, L., Navarra, A., Magri, F., Chiovato, L., Trimboli, P., & Rotondi, M. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12082934 · Cited by 9
Misleading FT4 and FT3 Due to Immunoassay Interference From Autoantibodies
Goettemoeller, T., McShane, A. J., & Rao, P. (2022) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2021.11.015 · Cited by 7
Köhrle, J., & Richards, K. H. (2020) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1175-4610 · Cited by 7
PEG Precipitation to Detect Macro‐TSH in Clinical Practice: A Systematic Review
Piticchio, T., Chiardi, I., Tumminia, A., Frasca, F., Rotondi, M., & Trimboli, P. (2024) · Clinical Endocrinology · doi:10.1111/cen.15179 · Cited by 7
Vincenzi, G., Petralia, I. T., Abbate, M. T. A., & Vigone, M. C. (2025) · European Thyroid Journal · doi:10.1530/etj-25-0019 · Cited by 8
Measuring the impact: Severity of harm from laboratory errors in 195 tests
Çubukçu, H. C., Cihan, M., Hakan, H., Bolat, S., Zengi, O., Uçar, K. T., Topçu, D. İ., Kılınçkaya, M. F., Özdemir, H., Gülşen, M., et al. (2024) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqae144 · Cited by 7
A Case of macro-TSH masquerading as subclinical hypothyroidism
D’Arcy, R., Hunter, S. J., Spence, K., & McDonnell, M. (2021) · BMJ Case Reports · doi:10.1136/bcr-2021-243436 · Cited by 7
Metadata
- Authors
- Favresse, J., Burlacu, M.-C., Maiter, D., & Gruson, D.
- Affiliations
- Cliniques Universitaires Saint-Luc (BE)
- Corresponding author
- Gruson, Damien
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2018-07-04
- Volume
- 39
- Issue
- 5
- Pages
- 830-850
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2894797166
- Cited by
- 258
- References
- 158
- Citations by year
- 2026: 33 · 2025: 27 · 2024: 20 · 2023: 47 · 2022: 35 · 2021: 36 · 2020: 37 · 2019: 21 · 2018: 2
- FWCI
- 3.15
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed (publishedVersion)
- DIAL (Catholic University of Leuven) (submittedVersion, other-oa)
- Funders
- Université Catholique de Louvain
- Topics
- Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Keywords
- thyroid function tests, immunoassay interference, thyroid-stimulating hormone, free thyroxine, free triiodothyronine, biotin interference, heterophile antibodies, detection algorithm, misdiagnosis, inappropriate treatment
- MeSH terms
- Algorithms, Humans, Immunoassay, Sensitivity and Specificity, Thyroid Function Tests, Thyrotropin, Thyroxine, Triiodothyronine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
